JBC Anatrace, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gilberger, T.-W.
Right arrow Articles by Müller, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gilberger, T.-W.
Right arrow Articles by Müller, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 272, Number 47, Issue of November 21, 1997 pp. 29584-29589

Identification and Characterization of the Functional Amino Acids at the Active Site of the Large Thioredoxin Reductase from Plasmodium falciparum*

(Received for publication, April 11, 1997, and in revised form, September 10, 1997)

Tim-Wolf Gilberger Dagger , Rolf D. Walter and Sylke Müller §

From the Bernhard Nocht Institute for Tropical Medicine, D-20359 Hamburg, Germany

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES


ABSTRACT

The thioredoxin system, composed of the pyridine nucleotide-disulfide oxidoreductase thioredoxin reductase, the small peptide thioredoxin, and NADPH as a reducing cofactor, is one of the major thiol-reducing systems of the cell. Recent studies revealed that Plasmodium falciparum and human thioredoxin reductase represent a novel class of enzymes, called large thioredoxin reductases. The large thioredoxin reductases are substantially different from the isofunctional prokaryotic Escherichia coli enzyme. The putative essential amino acids at the catalytic center of large thioredoxin reductase from P. falciparum were determined by using site-directed mutagenesis techniques. To analyze the putative active site cysteines (Cys88 and Cys93) three mutant proteins were constructed substituting alanine or serine residues for cysteine residues. Further, to evaluate the function of His509 as a putative proton donor/acceptor of large thioredoxin reductase this residue was replaced by either glutamine or alanine. All mutants were expressed in the E. coli system and characterized. Steady state kinetic analysis revealed that the replacement of Cys88 by either alanine or serine and Cys93 by alanine resulted in a total loss of enzymatic activity. These results clearly identify Cys88 and Cys93 as the active site thiols of large thioredoxin reductase. The replacement of His509 by glutamine yielded in a 95% loss of thioredoxin reductase activity; replacement by alanine provoked a loss of 97% of enzymatic activity. These results identify His509 as active site base, but imply that its function can be substituted, although inefficiently, by an alternative proton donor, similar to glutathione reductase. Spectral analysis of wild-type P. falciparum thioredoxin reductase revealed a 550-nm absorption band upon reduction which resembles the EH2 form of glutathione reductase and lipoamide dehydrogenase. This spectral feature, recently also reported for the human placenta protein (Arscott, L. D., Gromer, S., Schirmer, R. H., Becker K., and Williams, C. H., Jr. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 3621-3626), further illustrates the similarity between large thioredoxin reductases and glutathione reductases and stresses the profound differences to small E. coli thioredoxin reductase.


INTRODUCTION

The thioredoxin system composed of the small peptide thioredoxin (12 kDa), thioredoxin reductase (TrxR),1 and NADPH is involved in the maintenance of the crucial intracellular redox state (1). TrxR catalyzes the transfer of electrons from NADPH to thioredoxin, which itself acts as a reductant of disulfide-containing proteins, such as ribonucleotide reductase (2). TrxR is a member of the pyridine nucleotide-disulfide oxidoreductase family, which includes lipoamide dehydrogenase, glutathione reductase, mercuric ion reductase, and trypanothione reductase (3). Recently, TrxR from the human malaria parasite Plasmodium falciparum was cloned and recombinantly expressed in a prokaryotic expression system (4, 5). The amino acid sequence of the parasite protein shows a high degree of similarity to human TrxR, whereas both proteins have only moderate similarity to the well characterized Escherichia coli TrxR (5, 6). These data imply that two classes of clearly distinguishable TrxRs exist, large TrxRs, represented by human and P. falciparum TrxRs, with a subunit size of 58 and 64 kDa, respectively, and small TrxRs such as the prokaryotic E. coli protein, with a subunit size of 35 kDa (4-8). Both classes show local regions of strong similarity, such as the FAD binding site, but their primary structures are only distantly related. Based upon their amino acid sequences, large TrxRs are much more related to glutathione reductases than to their small counterparts (5, 6, 8). Spectral analyses of the human placenta TrxR revealed that the catalytic mechanism of large TrxR is similar to that of glutathione reductase and lipoamide dehydrogenase (8). The evolutionary background may be a convergent development of the small TrxR class and the large TrxR class, including glutathione reductase from one ancestor gene (9). The reaction sequence of the small E. coli enzyme was extensively examined, including investigations by site-directed mutagenesis (10, 11). These investigations led to the hypothesis that small TrxRs have to undergo a conformational change before they are able to exhibit their catalytic activity (11-13). To identify the active-site residues and to aid to the understanding of the catalytic mechanism of large TrxRs, we generated several mutations of P. falciparum TrxR (PfTrxR) and characterized the kinetic and spectral features of the wild-type and mutated recombinant proteins.


EXPERIMENTAL PROCEDURES

Mutagenic Oligonucleotides and Site-directed Mutagenesis

Ten oligonucleotides were designed to replace amino acid residues potentially involved in PfTrxR activity (Table I). The putative active site cysteines, Cys88 and Cys93, were changed to alanine. Residue Cys88 was also changed to serine. The putative active site base His509 was replaced by either alanine or glutamine. The replacement of the original amino acids with the desired ones was performed by an in vitro site-directed mutagenesis method according to Papworth et al. (14). By using high fidelity thermostable Pfu DNA polymerase, low cycle number, and primers designed only to copy the parental strand in a linear fashion, this method minimized unwanted second site mutations and generated mutants in a 1-day procedure. Briefly, the mutagenic oligonucleotides, complementary to the opposite strand of the double-stranded DNA template, were extended by the Pfu DNA polymerase during temperature cycling. 35 ng of the double-stranded, supercoiled expression plasmid pJC40PfTrxR (5) and 100 ng of mutagenic sense and antisense primers were used in a 50-µl reaction mixture containing deoxyribonucleotides, reaction buffer, and Pfu DNA polymerase according to the manufacturer's recommendations (Stratagene). The cycling parameters were 95 °C for 30 s, 55 °C for 1 min, and 68 °C for 8 min, 12 cycles. The linear amplification product was treated with endonuclease DpnI (10 units/µl, Boehringer Mannheim) for 1 h to eliminate the parental template. Subsequently, an aliqout of 6 µl of this reaction mixture containing the double-nicked mutated plasmid was used for the transformation of competent E. coli BL 21 (DE3) cells (Stratagene). All mutants were analyzed performing the Sanger dideoxy chain termination reaction for double-stranded DNA (15). 100% of the analyzed colonies contained the desired mutation in the absence of other unwanted mutations.

Table I. Mutagenic oligonucleotides for site-directed mutagenesis of PfTrxR

Nucleotides that were exchanged in order to obtain the desired mutation are underlined and in bold letters. Numbers in superscript indicate the position of nucleotides in the coding region of the gene.

5'  247GGTATAGGTGGAACGTGTGTGAACGTAGGATGTGTACC 3' C88WTa
5'  GGTATAGGTGGAACGGCTGTGAACGTAGGATGTGTACC 3' C88A (S)b
5'  GGTACACATCCTACGTTCACAGCCGTTCCACCTATACC 3' C88A (AS)c
5'  GGTATAGGTGGAACGTCTGTGAACGTAGGATGTGTACC 3' C88S (S)
5'  GGTACACATCCTACGTTCACAGACGTTCCACCTATACC 3' C88S (AS)
5'  265GTGAACGTAGGATGTGTACCAAAAAAATTAATGCAC 3' C93WT
5'  GTGAACGTAGGAGCTGTACCAAAAAAATTAATGCAC 3' C93A (S)
5'  GTGCATTAATTTTTTTGGTACAGCTCCTACGTTCAC 3' C93A (AS)
5' 1514GCATAGGTATTCATCCAACAGATGCTGAATCG 3' H509WT
5'  GCATAGGTATTCAACCAACAGATGCTGAATCG 3' H509Q (S)
5'  CGATTCAGCATCTGTTGGTTGAATACCTATGC 3' H509Q (AS)
5'  GCATAGGTATTGCTCCAACAGATGCTGAATCG 3' H509A (S)
5'  CGATTCAGCATCTGTTGGAGCAATACCTATGC 3' H509A (AS)

a WT, wild type.
b S, sense.
c AS, antisense.

Expression and Purification of Mutant Thioredoxin Reductase

The expression plasmid pJC40 (16), which contains a T7 promotor and encodes 10 histidine residues preceding the N terminus of the recombinant protein, was used for overexpression of the wild-type PfTrxR and all mutants in E. coli BL 21 (DE3) cells. E. coli BL 21 (DE3) cells carrying the expression plasmid containing the mutated cDNA were grown overnight at 37 °C in Luria-Bertani medium (containing 50 µg/ml ampicillin). The cells were diluted 100-fold into the same medium and grown until an A600 of 0.5 was reached. To induce the expression, 1 mM isopropyl-beta -D-thiogalactoside was added to the culture. The cells were harvested 4 h after induction by centrifugation (4000 × g; 10 min) and sonicated (Branson Sonifier 250) in binding buffer (20 mM Tris/HCl, 5 mM imidazole, 0.5 mM NaCl, pH 7.9), and the cell lysate was centrifugated at 100,000 × g for 1 h (Centrikon 1065, Kontron). The resulting supernatant was used for purification on Ni-nitrilotriacetic acid resin (Qiagen) in a batch procedure according to the manufacturer's recommendations. The purity of the recombinant proteins was assessed by SDS-polyacrylamide gel electrophoresis. Protein concentration was determined by the method of Bradford (17), with bovine serum albumin as a standard, and for spectral analyses the respective extinction coefficient was used for protein determination. To exchange the buffer system, recombinant proteins were dialyzed overnight against two changes of 2 liters of 20 mM Tris/HCl buffer containing 0.5 M NaCl and 1 mM EDTA, pH 7.9. For spectral analyses of PfTrxRC88A at various pH values, the buffer was exchanged by using Centricon 50 (Amicon) filters.

Thioredoxin Reductase Activity

The kinetic parameters of wild-type PfTrxR and all mutants were determined by the 5,5'-dithiobis (2-nitrobenzoate) (DTNB) reduction assay (5, 18). The mixture (1 ml; 20 °C) consisted of 100 mM potassium phosphate buffer, pH 7.4, 0.2 mg ml-1 bovine serum albumin, 2 mM EDTA, 2-4 µg ml-1 recombinant enzyme, 200 µM NADPH and 0.03-3 mM DTNB. For the determination of Km values for NADPH, NADPH concentrations were 1-50 µM and DTNB was 2 mM. The change in absorbance was monitored spectrophotometrically at 412 nm (Uvikon 932, Kontron). The activity was calculated using the molar absorption coefficient of thionitrobenzoate at 412 nm (13600 M-1 cm-1 per thionitrobenzoate unit).

FAD Contents and Extinction Coefficients

The extinction coefficients of the protein bound FAD in the 450-nm region were determined for all PfTrxRs. Enzyme-bound flavin was liberated by thermal denaturation at 100 °C for 30 min in the presence of 10 mM MgCl2. The denatured protein was precipitated by centrifugation (19). The concentration of free flavin was determined from its absorption coefficient at 450 nm of 11.3 × 103 M-1 cm-1.

Spectra

Spectral analyses of the oxidized form of the proteins were performed under aerobic conditions using 9-14 µM of wild-type and mutated PfTrxRs. Anaerobic spectra were performed by gently flushing oxygen-free nitrogen through the protein solution for 20 min followed by sealing the cuvette with a screw cap containing a septum adequate for anaerobic work or by overlaying the solution with mineral oil (19). The spectra reported (between 250 and 750 nm) were obtained using a thermostated spectrophotometer (Uvikon 932, Kontron) with a scan speed of 200 nm/min at 22 °C. Subsequently, an excess of NADPH was added to the cuvette and the spectral changes during the reduction process of the protein were determined. For anaerobic reduced spectra, NADPH was treated with oxygen-free nitrogen as described above and added to the oxidized protein using a gas-tight Hamilton syringe (19).


RESULTS

Expression of Thioredoxin Reductase Mutants in E. coli

It was previously reported that PfTrxR can be expressed as an active homodimer in the E. coli system (5). Expression and subsequent purification of wild-type PfTrxR, PfTrxRC88A, PfTrxRC88S, PfTrxRC93A, PfTrxRH509Q, and PfTrxRH509A yielded in 1-3.5 mg of pure protein liter-1 of bacterial culture. The purity of the proteins was determined by SDS-polyacrylamide gel electrophoresis (data not shown).

Kinetic Parameters of Wild-type and Mutated PfTrxR

The thiol reducing activities of wild-type and mutant PfTrxRs were compared based upon their kinetic properties (Table II). To evaluate the role of Cys88, Cys93, and His509 as putative catalytic active residues, the DTNB reduction assay was performed with wild-type and mutant proteins. Mutation of either Cys88 or Cys93 to alanine or serine resulted in a total loss of DTNB reducing activity, indicating that these residues are essential for enzymatic activity and most likely represent the active site thiols of the large PfTrxR. Replacement of His509 by either glutamine or alanine drastically decreased the reduction capacity of PfTrxR which implies that His509 represents the active site base of PfTrxR. PfTrxRH509Q retained about 5% of residual activity toward DTNB compared with the wild-type protein. To eliminate the possibility of a partial compensation of the imidazole side chain by the amido group of glutamine, we substituted His509 by alanine. However, the H509A mutant still retained 3% of the wild-type enzyme activity with DTNB. Although the turnover number of the histidine mutants decreased drastically, these mutants had a lower Km value for the model substrate DTNB (Table II). Additionally, the Km for NADPH of the H509A mutant decreased. A similar effect on the Km value for NADPH is well known for the same point mutation of the functionally homologous histidine residue in the E. coli glutathione reductase (20).

Table II. Apparent kinetic parameters for recombinant wild-type and mutant PfTrxRs

Data represent means (±S.E.) of three different enzyme preparations. The kinetic properties of the recombinant proteins were determined by the DTNB reduction assay.

Construct Specific activity kcat Km DTNB Km NADPH

units/mg min-1 µM
WT 4.30  ± 0.8 275.2  ± 51.2 212  ± 49 9  ± 0.7
C88A, C88S, C93A No activity
H509Q 0.22  ± 0.09 14.0  ± 5.8 50  ± 9 9  ± 0.6
H509Aa 0.15  ± 0.03 9.6  ± 1.9 147  ± 3 <2

a The true Km value for NADPH in this mutant could not be determined since the discrimination in rate could not be achieved even at a concentration of NADPH as low as 2 µM.

Spectral Characterization

Spectral analysis of oxidized wild-type PfTrxR under aerobic conditions shows a characteristic flavin spectrum with peaks around lambda 460 nm and lambda 380 nm (Fig. 1, line a). The lambda max for the oxidized enzyme is at 462 nm (epsilon  = 11.46 × 103 M-1 cm-1) (Table III) with a shoulder at 486 nm. During reduction of the enzyme under anaerobic conditions using 10 equivalents of NADPH/FAD, the 462-nm peak bleaches and a shoulder in the 550-nm region is formed. The lambda max of the reduced protein shifts with 26 nm toward the blue end of the spectrum, forming a peak at 436 nm (Fig. 1, line b). A similar spectral change was observed for other members of this protein family like glutathione reductase during the redox process (21, 22) and was recently reported for the human placenta TrxR (8).


Fig. 1. Spectra of wild-type PfTrxR (in 20 mM Tris/HCl containing 0.5 M NaCl and 1 mM EDTA, pH 7.9). a, oxidized wild-type PfTrxR (12 µM); b, reduced wild-type PfTrxR. Reduction was achieved by addition of 10 equivalents of NADPH/FAD under anaerobic conditions.

[View Larger Version of this Image (14K GIF file)]


Table III. Spectral properties of wild-type and mutant PfTrxRs

Data represent means (±S.E.) of three different enzyme preparations.

Enzyme  lambda max Absorption coefficient Charge transfer complex

nm mM-1 cm-1
WT 462 11.43  ± 0.95 +a
C88A 451 12.80  ± 1.40  -b
C88S 442 10.20  ± 0.73 +c
C93A 456 12.62  ± 1.20  -
H509A 462 13.58  ± 1.47  -
H509Q 460 11.40  ± 0.34  -

a A distinct shoulder with the lambda max at 550 nm is formed under anaerobic conditions in the presence of 10 equivalents of NADPH/FAD.
b No charge transfer complex at pH 7.9. A permanent charge transfer complex is inducible at pH values higher than 8.5.
c A permanent charge transfer complex is formed even in the absence of a reductant under aerobic conditions.

The absorption spectra of PfTrxRC88A (Fig. 2A) and PfTrxRC93A (Fig. 3) in the absence of reductant differ from wild-type PfTrxR by a shift of lambda max to the blue; PfTrxRC88A to 451 nm with an absorption coefficient of 12.80 × 103 M-1 cm-1, and PfTrxRC93A to 456 nm with an absorption coefficient of 12.62 × 103 M-1 cm-1 (Table III). PfTrxRC93A shows a normal oxidized spectrum, and the reduction leads to a decrease of the absorbance at 456 nm and a slight increase of the absorption at the 550-nm band. The exchange of the Cys88 with serine has drastic effects on the enzyme as expected if the charge transfer band is due to interaction of Cys93 with the protein-bound flavin. The purified protein has a brick-red color instead of being yellow as all other proteins. Spectral analysis of nonreduced PfTrxRC88S shows the presence of a charge transfer complex with a lambda max at 442 nm and a shoulder around 550 nm (Fig. 4), resembling the charge transfer produced in the EH2 species of glutathione reductase and trypanothione reductase (19, 21). Remarkably, PfTrxRC88A is yellow and shows only a slight increase of the absorbance at 550 nm compared with the oxidized wild-type protein, and addition of NADPH does not change the spectral features apart from bleaching the absorbance at 451 nm due to FAD reduction. Determination of the oxidized spectra of PfTrxRC88A at higher pH values resulted in spectral changes of the nonreduced protein. Fig. 2B shows the absorption spectrum at pH 7.9 (original conditions) and pH 10.6. Apart from the induction of a long wavelength band around 580 nm, the pH change from 7.9 to 10.6 resulted in a blue shift of the flavin peak by 21 nm. The appearance of the 580-nm band at higher pH values suggests that the alanine mutation of Cys88 affects the pK of Cys93, so that this residue is not in its thiolate form at pH values lower than 8.5 (Fig. 2C) and can thus not interact with the protein-bound flavin of PfTrxRC88A. Further, these data imply that Cys93 represents the charge transfer thiol of PfTrxR.


Fig. 2. A, spectra of PfTrxRC88A (in 20 mM Tris/HCl containing 0.5 M NaCl and 1 mM EDTA, pH 7.9). a, oxidized PfTrxRC88A (10 µM); b, reduced PfTrxRC88A. Reduction was achieved by addition of 10 equivalents of NADPH/FAD under anaerobic conditions. B, spectra of PfTrxRC88A at various pH values. a, oxidized PfTrxRC88A (8.8 µM) in 20 mM Tris/HCl, containing 0.5 M NaCl, pH 7.9. b, oxidized PfTrxRC88A (9.5 µM) in 200 mM glycine NaOH containing 0.5 M NaCl, pH 10.6. C, details of oxidized spectra of PfTrxRC88A between 500 and 800 nm using different buffer systems. 1 and 2, 20 mM Tris/HCl containing 0.5 M NaCl and 0.1 mM EDTA, pH 8.5 and 8.9, respectively. 3-5, 200 mM glycine NaOH containing 0.5 M NaCl and 0.1 mM EDTA at pH 9.5, 10.0, and 10.6, respectively.

[View Larger Version of this Image (14K GIF file)]



Fig. 3. Spectra of PfTrxRC93A (in 20 mM Tris/HCl containing 0.5 M NaCl and 1 mM EDTA, pH 7.9). a, oxidized PfTrxRC93A (12 µM); b, reduced PfTrxRC93A. Reduction was achieved by addition of 10 equivalents of NADPH/FAD under anaerobic conditions.

[View Larger Version of this Image (13K GIF file)]



Fig. 4. Spectra of PfTrxRC88S (in 20 mM Tris/HCl containing 0.5 M NaCl and 1 mM EDTA, pH 7.9). a, oxidized PfTrxRC88S (14 µM); b, reduced PfTrxRC88S. Reduction was achieved by addition of 10 equivalents of NADPH/FAD under anaerobic conditions.

[View Larger Version of this Image (13K GIF file)]



DISCUSSION

Large thioredoxin-reductases represented by the human, bovine and P. falciparum proteins differ considerably from the small E. coli TrxR (5, 6, 8, 11, 18). These two types of isofunctional enzymes are distinct in molecular mass, location of their active site residues, and most likely by their structure and catalytic mechanism (5, 6, 8). Molecular analyses of PfTrxR and the human enzyme revealed a high degree of similarity of both proteins to glutathione reductases rather than to E. coli TrxR, which is further supported by the results of Arscott et al. (8) for human TrxR and the data presented here for PfTrxR.

A series of PfTrxR mutants altered at the potential redox-active disulfide bridge (Cys88 and Cys93) and the potential active site base (His509) were generated to obtain more information about their role for the catalytic reaction of large TrxRs. The conversion of either one of the putative active site thiols, Cys88 and Cys93, into alanine or serine caused a complete inactivation of the thiol-reducing ability of PfTrxR. These data clearly identify Cys88 and Cys93 as essential amino acid residues involved in the catalysis of PfTrxR. Similar results were obtained when isofunctional residues were mutated in trypanothione reductase and glutathione reductase (19, 22). In contrast the replacement of the isofunctional residues in E. coli TrxR resulted in a residual activity of the mutant proteins of about 10%, which was explained by the different topology of the protein-bound flavin and the disulfide axis in comparison to other members of this protein family (11).

Further, it was demonstrated that His509 is involved in the catalytic mechanism of PfTrxR. The catalytic activity toward DTNB was drastically reduced but not completely eliminated with the substitution of the His509 by either glutamine or alanine. The residual activity of 5% after substitution of His509 by glutamine might be due to the hydrogen-bonding capacity of the glutamine residue or to the participation of another protonable side chain in the enzyme. To completely remove the potential hydrogen-bonding capacity, His509 was replaced by alanine. PfTrxRH509A still maintained 3% of catalytic activity with DTNB. This result implies that the function of His509 can be substituted, although inefficiently, by a nearby side chain that functions as an alternative proton acceptor/donor. These data are consistent with investigations on the E. coli glutathione reductase, where the analogous mutants H439Q and H439A retained 1 and 0.3%, respectively, of the activity of the wild-type enzyme (20). In contrast, in E. coli TrxR Asp139 rather than His245 functions as the acid catalyst for the dithiol-disulfide redox interconversion (23).

The most characteristic spectral feature of wild-type PfTrxR is the formation of a new 550-nm absorbance band upon NADPH reduction (Fig. 1). This long wavelength absorbance resembles other EH2 forms of related proteins (19, 21, 24). It is indicative of a thiolate flavin charge transfer complex as a stable intermediate of the two electron reduced form of the enzyme (25). Recently, the formation of a thiolate flavin charge transfer complex upon reduction with NADPH and dithionite was described for human TrxR (8) but does not occur in the E. coli enzyme (11, 26). The absorption spectrum of EH2 is influenced by complex formation with NADP+ and/or NADPH (27). Such a modulation might also occur in the spectrum reported here for the NADPH-reduced wild-type PfTrxR slightly increasing the absorbance around 550 nm.

To delineate the role of the active site cysteines and to identify the residue responsible for the thiolate flavin charge transfer interaction of EH2, we exchanged the putative active site cysteines of PfTrxR. In related flavoproteins such as glutathione reductase, trypanothione reductase, and mercuric ion reductase, the carboxyl-terminal cysteine residue of the redox active site is responsible for the formation of the thiolate flavin charge transfer complex (19, 24, 28). The replacement of Cys93 by alanine (PfTrxRC93A) does not change the spectral features of the oxidized form of the protein. Upon reduction with an excess of NADPH a slight increase of the 550-nm band occurs (Fig. 3). This might be due to the binding of excess NADPH to the reduced protein. The replacement of the other active site cysteine Cys88 resulted in conspicuous spectral properties. While a serine at this position leads to the expected distinctive absorption spectrum of the oxidized protein resembling a permanent charge transfer complex even under nonreductive conditions (Fig. 4), the alanine mutant protein reveals just a slight increase at the 550 nm band (Fig. 2A). The absence of the long wavelength band in PfTrxRC88A in the absence of the reducing agent was unanticipated, providing that the carboxyl-terminal Cys93 represents the charge transfer thiol within the PfTrxR active site. At higher pH values between 8.5 and 10.6 the thiolate charge transfer complex in the oxidized PfTrxRC88A was induced (Fig. 2, B and C), indicating that in this mutant protein Cys93 is not in its thiolate form at pH values lower than 8.5. These data imply that the pK of Cys93 was altered within the protein due to the C88A mutation. The long wavelength band in monoalkylated lipoamide dehydrogenase (EHR) is also missing as shown by Thorpe and Williams (29). Probably the alkylation of the amino-terminal cysteine residue sufficiently perturbs the environment of the charge transfer donor and might increase its pK (21). However, in this case binding of 3-aminopyridine adenine dinucleotide to pig heart lipoamide dehydrogenase induces the appearance of the long wavelength band and is assigned to a charge transfer complex between the carboxyl-terminal thiolate and the protein-bound flavin (30). In glutathione reductase monoalkylated at the amino-terminal cysteine residue, the long wavelength band is fully retained (21). Decreasing the pH value to 3.5 results in almost a complete loss of the charge transfer absorbance; increasing the pH to 10.3 yields a blue shift of the FAD band and increases the long wavelength absorbance (31), also seen in PfTrxRC88A (Fig. 2B).

In conclusion, the data presented here suggest fundamental differences between small TrxRs and large TrxRs. Cys88, Cys93, and His509 were identified as essential active site residues of PfTrxR. Equivalent residues are responsible for the enzymatic activity of glutathione reductase, whereas in E. coli TrxR the active site residues show a completely different topology (9, 11). Further, the formation of a stable thiolate flavin charge transfer complex implies that the reaction mechanism of large TrxRs is similar to glutathione reductase and lipoamide dehydrogenase as it has also been suggested by Arscott et al. (8). However, the fact that PfTrxRC88A does not show the expected charge transfer band at pH values lower than 8.5 hints toward distinctive differences in the architecture of the catalytic center of glutathione reductase and PfTrxR, that demand more detailed studies dealing with the acid-base chemistry of the PfTrxR active site. In addition, crystallographic analysis of the three-dimensional structure will be necessary to conclusively discuss the active site geometry of the protein.


FOOTNOTES

*   The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Dagger    This article is based on a portion of the doctoral research performed by this author at the University of Hamburg.
§   To whom correspondence should be addressed: Biochemical Parasitology, Bernhard Nocht Institute for Tropical Medicine, Bernhard-Nocht-Str. 74, D-20359 Hamburg, Germany. Tel.: 49 40 31182416; Fax: 49 40 31182418.
1   The abbreviations used are: TrxR, thioredoxin reductase; PfTrxR, Plasmodium falciparum TrxR; PfTrxRC88A, PfTrxR containing alanine at position 88 instead of cysteine; PfTrxRC88S, PfTrxR containing serine at position 88 instead of cysteine; PfTrxRC93A, PfTrxR containing alanine at position 93 instead of cysteine; PfTrxRH509A, PfTrxR containing alanine at position 509 instead of histidine; PfTrxRH509Q, PfTrxR containing glutamine at position 509 instead of histidine; DTNB, 5,5'-dithiobis (2-nitrobenzoate).

REFERENCES

  1. Holmgren, A., and Björnstedt, M. (1995) Methods Enzymol. 252, 199-208 [CrossRef][Medline] [Order article via Infotrieve]
  2. Holmgren, A. (1989) J. Biol. Chem. 264, 13963-13966 [Free Full Text]
  3. Ghisla, S., and Massey, V. (1989) Eur. J. Biochem 181, 1-17 [Medline] [Order article via Infotrieve]
  4. Müller, S., Becker, K., Bergmann, B., Schirmer, R. H., and Walter, R. D. (1995) Mol. Biochem. Parasitol. 74, 11-18 [Medline] [Order article via Infotrieve]
  5. Müller, S., Gilberger, T.-W., Färber, P. M., Becker, K., Schirmer, R. H., and Walter, R. D. (1996) Mol. Biochem. Parasitol. 80, 215-219 [CrossRef][Medline] [Order article via Infotrieve]
  6. Gasdaska, P. Y., Gasdaska, J. R., Cochran, S., and Powis, G. (1995) FEBS Lett. 373, 5-9 [CrossRef][Medline] [Order article via Infotrieve]
  7. Russel, M., and Model, P. (1988) J. Biol. Chem. 263, 9015-9019 [Abstract/Free Full Text]
  8. Arscott, D. L., Gromer, S., Schirmer, R. H., Becker, K., and Williams, C. H., Jr. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 3621-3626 [Abstract/Free Full Text]
  9. Kyurian, J., Krishna, T. S. R., Wong, L., Guenther, B., Pahler, A., Williams, C. H., and Model, P. (1991) Nature 352, 172-174 [CrossRef][Medline] [Order article via Infotrieve]
  10. Prongay, A. J., Engelke, D. R., and Williams, C. H., Jr. (1989) J. Biol. Chem. 264, 2656-2664 [Abstract/Free Full Text]
  11. Williams, C. H., Jr. (1995) FASEB J. 9, 1267-1276 [Abstract]
  12. Waksman, G., Krishna, T. S. R., Williams, C. H., Jr., and Kuriyan, J. (1994) J. Mol. Biol. 236, 800-816 [CrossRef][Medline] [Order article via Infotrieve]
  13. Wang, P.-F., Veine, D. M., Ahn, S. H., and Williams, C. H., Jr. (1996) Biochemistry 35, 4812-4819 [CrossRef][Medline] [Order article via Infotrieve]
  14. Papworth, C., Bauer, J. C., Braman, J., and Wright, D. A. (1996) Strategies 9, 3-4
  15. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd Ed., Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  16. Clos, J., and Brandau, S. (1994) Protein Exp. Purif. 5, 133-137 [CrossRef][Medline] [Order article via Infotrieve]
  17. Bradford, M. M. (1976) Anal. Biochem. 72, 248-254 [CrossRef][Medline] [Order article via Infotrieve]
  18. Oblong, J. E., Gasdaska, P. Y., Sherrill, K., and Powis, G. (1993) Biochemistry 33, 7271-7277
  19. Borges, A., Cunningham, M. L., Tovar, J., and Fairlamb, A. H. (1995) Eur. J. Biochem. 228, 745-752 [Medline] [Order article via Infotrieve]
  20. Deonarain, M. P., Berry, A., Scrutton, N. S., and Perham, R. N. (1989) Biochemistry 28, 9602-9607 [CrossRef][Medline] [Order article via Infotrieve]
  21. Arscott, L. D., Thorpe, C., and Williams, C. H., Jr. (1981) Biochemistry 20, 1513-1520 [CrossRef][Medline] [Order article via Infotrieve]
  22. Deonarain, M. P., Scrutton, N. S., Berry, A., and Perham, R. N. (1990) Proc. R. Soc. London Ser. B 241, 179-186 [Medline] [Order article via Infotrieve]
  23. Mulrooney, S. B., and Williams, C. H., Jr. (1994) Biochemistry 33, 3148-3154 [Medline] [Order article via Infotrieve]
  24. Distefano, M. D., Au, K. G., and Walsh, C. T. (1989) Biochemistry 28, 1168-1183 [Medline] [Order article via Infotrieve]
  25. Massey, V., and Ghisla, S. (1974) Ann. N. Y. Acad. Sci. 227, 446-465 [CrossRef]
  26. Zanetti, G., and Williams, C. H., Jr. (1967) J. Biol. Chem. 242, 5232-5236 [Abstract/Free Full Text]
  27. Sahlman, L., Lambeir, A. M., Lindskog, S., and Dunford, H. B. (1984) J. Biol. Chem. 259, 12403-12408 [Abstract/Free Full Text]
  28. Pai, E. F., and Schulz, G. E. (1983) J. Biol. Chem. 258, 1752-1757 [Abstract/Free Full Text]
  29. Thorpe, C., and Williams, C. H., Jr. (1976) J. Biol. Chem. 251, 3553-3557 [Abstract/Free Full Text]
  30. Thorpe, C., and Williams, C. H., Jr. (1981) Biochemistry 20, 1507-1513 [Medline] [Order article via Infotrieve]
  31. Sahlman, L., and Williams, C. H., Jr. (1989) J. Biol. Chem. 264, 8033-8038 [Abstract/Free Full Text]

Volume 272, Number 47, Issue of November 21, 1997 pp. 29584-29589
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
P. J. McMillan, L. D. Arscott, D. P. Ballou, K. Becker, C. H. Williams Jr., and S. Muller
Identification of Acid-Base Catalytic Residues of High-Mr Thioredoxin Reductase from Plasmodium falciparum
J. Biol. Chem., November 3, 2006; 281(44): 32967 - 32977.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. I. Biterova, A. A. Turanov, V. N. Gladyshev, and J. J. Barycki
Crystal structures of oxidized and reduced mitochondrial thioredoxin reductase provide molecular details of the reaction mechanism
PNAS, October 18, 2005; 102(42): 15018 - 15023.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. E. Akerman and S. Muller
Peroxiredoxin-linked Detoxification of Hydroperoxides in Toxoplasma gondii
J. Biol. Chem., January 7, 2005; 280(1): 564 - 570.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Krnajski, T.-W. Gilberger, R. D. Walter, A. F. Cowman, and S. Muller
Thioredoxin Reductase Is Essential for the Survival of Plasmodium falciparum Erythrocytic Stages
J. Biol. Chem., July 12, 2002; 277(29): 25970 - 25975.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Krnajski, T.-W. Gilberger, R. D. Walter, and S. Muller
Intersubunit Interactions in Plasmodium falciparum Thioredoxin Reductase
J. Biol. Chem., December 22, 2000; 275(52): 40874 - 40878.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gilberger, T.-W.
Right arrow Articles by Müller, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gilberger, T.-W.
Right arrow Articles by Müller, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.